Edwards Lifesciences
407 hedge funds and large institutions have $6.52B invested in Edwards Lifesciences in 2013 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 111 increasing their positions, 174 reducing their positions, and 67 closing their positions.
38.54% more ownership
Funds ownership: 506.22% → 544.76% (+39%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% less funds holding
Funds holding: 409 → 407 (-2)
1% less capital invested
Capital invested by funds: $6.58B → $6.52B (-$58.1M)
1% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 67
8% less call options, than puts
Call options by funds: $81.4M | Put options by funds: $88.8M
36% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 174
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$270M |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$186M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$126M |
| 4 |
JP
Jana Partners
New York
|
+$105M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$52.3M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$101M |
| 2 |
BAMCO Inc
New York
|
-$43.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$42.7M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$42.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$41.1M |
EW Hedge Fund Activity: Q4 2013 in Review
407 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q4 2013, worth a combined $6.52B — down 0.88% from $6.58B a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of EW and 66 opened new positions — a net loss of 1 holder — while 174 trimmed existing stakes and 111 added.
The largest buyer was Wellington Management Group, adding an estimated $270M. The largest seller was Goldman Sachs, cutting an estimated $101M.
- 407 institutional investors held Edwards Lifesciences (EW) as of Q4 2013, down from 409 in Q3 2013.
- Funds reported $6.52B of Edwards Lifesciences stock for Q4 2013, down 0.88% quarter-over-quarter.
- 66 funds opened new Edwards Lifesciences positions in Q4 2013 and 67 closed out, a net change of -1 holder.
- The largest Edwards Lifesciences buyer in Q4 2013 was Wellington Management Group, an estimated $270M added.
- The largest Edwards Lifesciences seller in Q4 2013 was Goldman Sachs, an estimated $101M sold.
Based on aggregated 13F filings for Q4 2013.